Cancer Research UK logo.
SearchDonate
  • Search

A trial comparing treatments for a brain tumour called medulloblastoma (HR-MB)

Overview

Cancer types:

Brain (and spinal cord) tumours, Children's cancers

Status:

Open

Phase:

Phase 3

Details

This trial is comparing treatments after surgery for high risk medulloblastoma. It is for children and adults.

It is for people who have a higher risk of their tumour coming back after treatment.

Medulloblastoma is most commonly diagnosed in children. Teenagers and adults can also get it.

We use the term ‘you’ in this summary but if you are a parent we are referring to your child.

Cancer Research UK supports this trial.

Recruitment start: 19 January 2021

Recruitment end: 31 December 2029

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Simon Bailey

Supported by

Cancer Research UK

The Brain Tumour Charity

University of Birmingham

Other information

This is Cancer Research UK trial number CRUK/17/019.

Last reviewed: 12 May 2025

CRUK internal database number: 15464

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.